These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 9094381)
1. Cyclophosphamide is neuroprotective in a gerbil model of transient severe focal cerebral ischemia: correlation with effects of tirilazad mesylate (U-74006F). Williams LR; Oostveen JA; Hall ED; Jolly RA; Satoh PS; Petry TW J Neurotrauma; 1996 Feb; 13(2):103-13. PubMed ID: 9094381 [TBL] [Abstract][Full Text] [Related]
2. Effects of the lipid peroxidation inhibitor tirilazad mesylate (U-74006F) on gerbil brain eicosanoid levels following ischemia and reperfusion. Andrus PK; Taylor BM; Sun FF; Hall ED Brain Res; 1994 Oct; 659(1-2):126-32. PubMed ID: 7820653 [TBL] [Abstract][Full Text] [Related]
3. Pyrrolopyrimidines: novel brain-penetrating antioxidants with neuroprotective activity in brain injury and ischemia models. Hall ED; Andrus PK; Smith SL; Fleck TJ; Scherch HM; Lutzke BS; Sawada GA; Althaus JS; Vonvoigtlander PF; Padbury GE; Larson PG; Palmer JR; Bundy GL J Pharmacol Exp Ther; 1997 May; 281(2):895-904. PubMed ID: 9152399 [TBL] [Abstract][Full Text] [Related]
4. Effects of the 21-amino steroid tirilazad mesylate (U-74006F) on brain damage and edema after perinatal hypoxia-ischemia in the rat. Bågenholm R; Andiné P; Hagberg H Pediatr Res; 1996 Sep; 40(3):399-403. PubMed ID: 8865275 [TBL] [Abstract][Full Text] [Related]
5. Neuroprotective efficacy of microvascularly-localized versus brain-penetrating antioxidants. Hall ED; Andrus PK; Smith SL; Oostveen JA; Scherch HM; Lutzke BS; Raub TJ; Sawada GA; Palmer JR; Banitt LS; Tustin JS; Belonga KL; Ayer DE; Bundy GL Acta Neurochir Suppl; 1996; 66():107-13. PubMed ID: 8780807 [TBL] [Abstract][Full Text] [Related]
6. Effects of tirilazad mesylate on postischemic brain lipid peroxidation and recovery of extracellular calcium in gerbils. Hall ED; Pazara KE; Braughler JM Stroke; 1991 Mar; 22(3):361-6. PubMed ID: 2003306 [TBL] [Abstract][Full Text] [Related]
7. Dose-response analysis of the effect of 21-aminosteroid tirilazad mesylate (U-74006F) upon neurological outcome and ischemic brain damage in permanent focal cerebral ischemia. Park CK; Hall ED Brain Res; 1994 May; 645(1-2):157-63. PubMed ID: 8062078 [TBL] [Abstract][Full Text] [Related]
8. Therapeutic effect of tirilazad mesylate (U-74006F), mannitol, and their combination on experimental ischemia. Oktem IS; Menkü A; Akdemir H; Kontaş O; Kurtsoy A; Koç RK Res Exp Med (Berl); 2000 Feb; 199(4):231-42. PubMed ID: 10743681 [TBL] [Abstract][Full Text] [Related]
9. Ischemia-related changes in naive and mutant forms of ubiquitin and neuroprotective effects of ubiquitin in the hippocampus following experimental transient ischemic damage. Ahn HC; Yoo KY; Hwang IK; Cho JH; Lee CH; Choi JH; Li H; Cho BR; Kim YM; Won MH Exp Neurol; 2009 Nov; 220(1):120-32. PubMed ID: 19666022 [TBL] [Abstract][Full Text] [Related]
10. Tirilazad prevention of reperfusion edema after focal ischemia in cynomolgus monkeys. Boisvert DP; Hall ED Can J Neurol Sci; 1996 Feb; 23(1):46-52. PubMed ID: 8673962 [TBL] [Abstract][Full Text] [Related]
11. Protective effects of tirilazad mesylate and metabolite U-89678 against blood-brain barrier damage after subarachnoid hemorrhage and lipid peroxidative neuronal injury. Smith SL; Scherch HM; Hall ED J Neurosurg; 1996 Feb; 84(2):229-33. PubMed ID: 8592225 [TBL] [Abstract][Full Text] [Related]
12. The use of salicylate hydroxylation to detect hydroxyl radical generation in ischemic and traumatic brain injury. Reversal by tirilazad mesylate (U-74006F). Althaus JS; Andrus PK; Williams CM; VonVoigtlander PF; Cazers AR; Hall ED Mol Chem Neuropathol; 1993 Oct; 20(2):147-62. PubMed ID: 8297419 [TBL] [Abstract][Full Text] [Related]
13. Tirilazad treatment does not decrease early brain injury after transient focal ischemia in cats. Takeshima R; Kirsch JR; Koehler RC; Traystman RJ Stroke; 1994 Mar; 25(3):670-6. PubMed ID: 8128524 [TBL] [Abstract][Full Text] [Related]
14. Tirilazad reduces cortical infarction after transient but not permanent focal cerebral ischemia in rats. Xue D; Slivka A; Buchan AM Stroke; 1992 Jun; 23(6):894-9. PubMed ID: 1595111 [TBL] [Abstract][Full Text] [Related]
15. Lack of evidence for neutrophil participation during infarct formation following focal cerebral ischemia in the rat. Hayward NJ; Elliott PJ; Sawyer SD; Bronson RT; Bartus RT Exp Neurol; 1996 Jun; 139(2):188-202. PubMed ID: 8654522 [TBL] [Abstract][Full Text] [Related]
16. Amelioration of impaired cerebral metabolism after severe acidotic ischemia by tirilazad posttreatment in dogs. Kim H; Koehler RC; Hurn PD; Hall ED; Traystman RJ Stroke; 1996 Jan; 27(1):114-21. PubMed ID: 8553386 [TBL] [Abstract][Full Text] [Related]
17. Effect of the 21-aminosteroid tirilazad on cerebral pH and somatosensory evoked potentials after incomplete ischemia. Maruki Y; Koehler RC; Kirsch JR; Blizzard KK; Traystman RJ Stroke; 1993 May; 24(5):724-30. PubMed ID: 8488529 [TBL] [Abstract][Full Text] [Related]
18. Tirilazad mesylate protects vitamins C and E in brain ischemia-reperfusion injury. Sato PH; Hall ED J Neurochem; 1992 Jun; 58(6):2263-8. PubMed ID: 1573405 [TBL] [Abstract][Full Text] [Related]
19. Effect of tirilazad mesylate given after permanent middle cerebral artery occlusion in rat. Hellström HO; Wanhainen A; Valtysson J; Persson L; Hillered L Acta Neurochir (Wien); 1994; 129(3-4):188-92. PubMed ID: 7847162 [TBL] [Abstract][Full Text] [Related]
20. Tirilazad mesylate attenuates the accumulation of neutrophils in ischemic gerbil brain. Williams LR; Oostveen JA Ann N Y Acad Sci; 1993 May; 679():330-5. PubMed ID: 8390146 [No Abstract] [Full Text] [Related] [Next] [New Search]